DE69819643T2 - Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay - Google Patents
Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay Download PDFInfo
- Publication number
- DE69819643T2 DE69819643T2 DE69819643T DE69819643T DE69819643T2 DE 69819643 T2 DE69819643 T2 DE 69819643T2 DE 69819643 T DE69819643 T DE 69819643T DE 69819643 T DE69819643 T DE 69819643T DE 69819643 T2 DE69819643 T2 DE 69819643T2
- Authority
- DE
- Germany
- Prior art keywords
- immunoassay
- antigen
- infectious agent
- hiv
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 83
- 102000036639 antigens Human genes 0.000 title claims abstract description 83
- 108091007433 antigens Proteins 0.000 title claims abstract description 83
- 238000003018 immunoassay Methods 0.000 title claims abstract description 54
- 238000011534 incubation Methods 0.000 title claims description 15
- 239000012678 infectious agent Substances 0.000 claims abstract description 35
- 208000031886 HIV Infections Diseases 0.000 claims description 8
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 6
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 5
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 29
- 208000015181 infectious disease Diseases 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000002458 infectious effect Effects 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 241000725303 Human immunodeficiency virus Species 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241001227713 Chiron Species 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000037357 HIV infectious disease Diseases 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000220259 Raphanus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001378 electrochemiluminescence detection Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9719357.7A GB9719357D0 (en) | 1997-09-11 | 1997-09-11 | Immunoassay Utilizing Two Incubations With Labelled Antigen |
| GB9719357 | 1997-09-11 | ||
| US09/141,887 US6121006A (en) | 1997-09-11 | 1998-08-28 | Immunoassay utilizing two incubations with labeled antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69819643D1 DE69819643D1 (de) | 2003-12-18 |
| DE69819643T2 true DE69819643T2 (de) | 2004-12-02 |
Family
ID=26312227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69819643T Expired - Lifetime DE69819643T2 (de) | 1997-09-11 | 1998-09-10 | Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6121006A (enExample) |
| EP (1) | EP0902286B1 (enExample) |
| JP (1) | JPH11148936A (enExample) |
| AT (1) | ATE254286T1 (enExample) |
| CA (1) | CA2246896C (enExample) |
| DE (1) | DE69819643T2 (enExample) |
| DK (1) | DK0902286T3 (enExample) |
| ES (1) | ES2210678T3 (enExample) |
| GB (1) | GB9719357D0 (enExample) |
| PT (1) | PT902286E (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458528B1 (en) | 1998-05-15 | 2002-10-01 | Idexx Laboratories, Inc. | Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers |
| CA2446246A1 (en) * | 2001-05-03 | 2002-11-14 | Immunetics, Inc. | Systems and methods for detection of analytes in biological fluids |
| US7262019B2 (en) * | 2001-05-03 | 2007-08-28 | Immunetics, Inc. | System and methods for detection of Bacillus anthracis related analytes in biological fluids |
| GB0128583D0 (en) * | 2001-11-28 | 2002-01-23 | Rsr Ltd | Detection of autoantibodies indicative of diabetes |
| US7514191B2 (en) * | 2006-04-26 | 2009-04-07 | Xerox Corporation | Imaging member |
| AU2011230619C1 (en) | 2010-03-25 | 2016-06-23 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
| HRP20180607T1 (hr) | 2011-06-10 | 2019-04-05 | Oregon Health & Science University | Glikoproteini i rekombinantni vektori cmv |
| CA2789539A1 (en) | 2011-09-12 | 2013-03-12 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| KR101990958B1 (ko) * | 2016-08-31 | 2019-06-21 | 휴마시스 주식회사 | 면역학적 측정을 이용한 hiv 1형, 2형 및 o형 동시 진단용 키트 및 이를 이용한 동시 진단방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4789628A (en) * | 1986-06-16 | 1988-12-06 | Vxr, Inc. | Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices |
| EP0366673B1 (en) * | 1987-06-09 | 1992-09-16 | Cambridge Life Sciences Plc | Immunoassay method |
| DE3854834T2 (de) * | 1987-10-30 | 1996-06-27 | Abbott Lab | Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen |
| US5683864A (en) * | 1987-11-18 | 1997-11-04 | Chiron Corporation | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| DE4120412C1 (enExample) * | 1991-06-20 | 1993-01-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De |
-
1997
- 1997-09-11 GB GBGB9719357.7A patent/GB9719357D0/en not_active Ceased
-
1998
- 1998-08-28 US US09/141,887 patent/US6121006A/en not_active Expired - Lifetime
- 1998-09-08 CA CA002246896A patent/CA2246896C/en not_active Expired - Lifetime
- 1998-09-10 PT PT98307328T patent/PT902286E/pt unknown
- 1998-09-10 ES ES98307328T patent/ES2210678T3/es not_active Expired - Lifetime
- 1998-09-10 DE DE69819643T patent/DE69819643T2/de not_active Expired - Lifetime
- 1998-09-10 DK DK98307328T patent/DK0902286T3/da active
- 1998-09-10 AT AT98307328T patent/ATE254286T1/de active
- 1998-09-10 EP EP98307328A patent/EP0902286B1/en not_active Expired - Lifetime
- 1998-09-11 JP JP10258444A patent/JPH11148936A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2210678T3 (es) | 2004-07-01 |
| DE69819643D1 (de) | 2003-12-18 |
| PT902286E (pt) | 2004-03-31 |
| GB9719357D0 (en) | 1997-11-12 |
| CA2246896C (en) | 2006-04-04 |
| EP0902286A2 (en) | 1999-03-17 |
| CA2246896A1 (en) | 1999-03-11 |
| EP0902286A3 (en) | 2000-02-23 |
| DK0902286T3 (da) | 2004-02-02 |
| JPH11148936A (ja) | 1999-06-02 |
| EP0902286B1 (en) | 2003-11-12 |
| ATE254286T1 (de) | 2003-11-15 |
| US6121006A (en) | 2000-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69819643T2 (de) | Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay | |
| DE68924878T2 (de) | Bestimmung eines felinen pathogen-specifischen Antikörpers und eines felinen pathogenen Antigens in einem Immuntest. | |
| DE68922243T2 (de) | Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde. | |
| DE60120067T2 (de) | Nachweis von mehreren Analyten in einer einzelnen Probe unter Verwendung eines diagnostischen Mehrgefäss-, Multianalyten-, Durchfluss-Testelementes | |
| DE68918166T2 (de) | Spezifische Bindungszusammensetzung mit einem Protein oder einem Kohlenhydrat mit Nieder-pI und ein diagnostischer Testsatz und Verfahren zur Anwendung. | |
| DE3882705T2 (de) | Immunoglobulin-bestimmungsverfahren. | |
| CA1321045C (en) | Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor | |
| DE69823531T2 (de) | Bovine virale diarrhöe virus serumantigen fangimmuntest | |
| EP0957360B1 (de) | Entstörung durch Rheumafaktoren | |
| EP0703452A2 (de) | Verfahren zum qualitativen und/oder quantitativen Nachweis einer zu bestimmenden Substanz | |
| EP0875761B1 (de) | Immunoassay zur Aviditätsbestimmung von Immunglobulinen | |
| DE68924272T2 (de) | Verfahren zur vorbehandlung von mustern bei peroxidase-katalysierten enzymtestverfahren. | |
| DE69008743T2 (de) | Extraktionszusammensetzung, Testsatz und deren Verwendung zum Nachweis von Herpes-Simplex-Antigen. | |
| Thongcharoen et al. | Immunoglobulin G antibody capture enzyme-linked immunosorbent assay: a versatile assay for detection of anti-human immunodeficiency virus type 1 and 2 antibodies in body fluids | |
| EP0265851B1 (de) | Verfahren zur Bestimmung von Anti-HIV, Mittel dazu und ihre Verwendung in diesem Verfahren | |
| Sanders et al. | Routine detection of human rota virus by latex agglutination: Comparison with enzyme-linked immunosorbent assay, electron microscopy and polyacrylamide gel electrophoresis | |
| DE69606024T2 (de) | Feststellung von antikörperproduktion | |
| DE3854834T2 (de) | Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen | |
| DE69528311T2 (de) | Enzym-verknüpfte Chemilumineszenzbestimmung | |
| DE69119445T2 (de) | Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus) | |
| DE3854603T2 (de) | Teststreifen für diagnose durch multi-immunoassay system. | |
| DE69404022T2 (de) | Eintopftest | |
| EP0538703B1 (de) | Verfahren zum Nachweisen der An- oder Abwesenheit von Epstein-Barr-Virus Infektionen | |
| DE3202559A1 (de) | Verfahren zum nachweis von igm-antikoerpern gegen hepatitis a-virus und reagens zur durchfuehrung von immunoassays | |
| DE19913117A1 (de) | Entstörung durch Rheumafaktoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8328 | Change in the person/name/address of the agent |
Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN |